SCHEMBL6989835

SCHEMBL6989835

CS(=O)(=O)c1ncc2ncnc(Nc3ccc(OCc4ccccc4)c(Cl)c3)c2n1

nearest known ligand 0.57

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
EGFR P00533 17/20 0.57
ERBB2 P04626 14/20 0.55
GRM4 Q14833 1/20 0.48
GAK O14976 1/20 0.47
ERBB3 P21860 1/20 0.46
ERBB4 Q15303 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7090432 0.88 EGFR (0.56) EGFRERBB2ERBB3ERBB4
SCHEMBL6993612 0.85 EGFR (0.56) EGFRERBB2ERBB4
SCHEMBL6989584 0.85 EGFR (0.47) EGFRERBB2ERBB4
SCHEMBL7001208 0.83 EGFR (0.55) EGFRERBB2GRM4GAKERBB3
SCHEMBL8317145 0.83 EGFR (0.49) EGFRERBB2
SCHEMBL6990215 0.81 EGFR (0.53) EGFRERBB2GRM4GAKERBB3
SCHEMBL6989068 0.81 EGFR (0.57) EGFRERBB2ERBB4
SCHEMBL6990190 0.80 EGFR (0.59) EGFRERBB2ERBB4
SCHEMBL6417047 0.80 EGFR (0.66) EGFRERBB2
SCHEMBL8315829 0.78 EGFR (0.51) EGFRGRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888351-B1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION THOMAE GMBH DR K (DE) 2003-10-15 EP disclosed
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP disclosed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO disclosed